$56.19
-0.71-1.25%
Últ. Act.: Sep 25, 1:13 PM

Vaxcyte (PCVX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.97 | $-1.79 | $-1.49 | $-1.25 |
| Actual | $-1.97 | $-2.30 | $-1.80 | $-1.56 |
| Surprise | 0.00% | -28.5% | -20.8% | -24.8% |
| Revenue | ||||
| Estimate | $12.5M | $12.5M | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-2.08 | $-2.01 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-1.97 | $-1.97 | 0.00 % |
| Q1 | May 6, 2026 | $-2.30 | $-1.79 | -28.5 % |
| Q4 | Feb 24, 2026 | $-1.80 | $-1.49 | -20.8 % |
| Q3 | Nov 4, 2025 | $-1.56 | $-1.25 | -24.8 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0 | $12.50M | -100.0 % |
| Q1 | May 6, 2026 | $0 | $12.50M | -100.0 % |